Dirk Groenewegen

Dirk Groenewegen is a seasoned professional in business development within the regenerative medicine and cell & gene therapy sectors, currently serving as Managing Director at Cells4Therapy since January 2017. Groenewegen possesses extensive expertise in market transfer, intellectual property strategies, and funding avenues such as non-dilutive funding, equity investment, and venture capital across the Benelux, Germany, UK, and US. Additionally, Groenewegen holds positions as a Strategic Advisor at Limula and a Mentor at Stichting O3NL, which aids emerging entrepreneurs. Previously, Groenewegen was the CEO and Board Director of Glycostem Therapeutics from September 2005 to December 2017 and is also a Business Advisor for PhosPrint P.C. Dirk Groenewegen earned an M.Sc. in Chemical Engineering from Delft University of Technology and a Dr. in Microbiology from the University of Hamburg, complemented by a course in Pharma-Biotech Product & Company Valuation from CELforPharma.